Letrozole 2.5 mg

HALTRO 2.5 is tablets containing Letrozole USP 2.5 mg, supplied in 20×5 Blister packing to Halefem Gynae’s PCD franchise partners, stockists and distributors across India.

Composition

• Letrozole USP 2.5 mg

Presentation

Dosage form: Tablets
Pack: 20×5 Blister
Brand: HALTRO 2.5

Where it sits in the range

HALTRO 2.5 belongs to Halefem’s female infertility & pcos-pcod management series. The companion strength to Haltro 5. Between them they cover the letrozole side of ovulation induction; the clomiphene side is covered by the Clomihal line.

What distributors ask about this line

Why is letrozole worth stocking in a gynae range?
It is first-line for a large share of ovulation induction prescribing, particularly in PCOS. A gynae range without it is visibly incomplete to a fertility prescriber.

Is it supplied on monopoly rights?
Yes, like the rest of the range — one partner per district, written into the agreement.

Can it be ordered alongside the rest of the fertility series?
Yes. Progesterone, DHEA, hCG, menotrophins and the inositol line all ship on the same order, which is the point of carrying a full series.

Supply and franchise terms

Available on gynae PCD franchise with one partner per district, recorded in the written agreement rather than promised on a call. A valid wholesale drug licence and GST registration in the partner’s own name are required before supply. Price list issued on request against your intended product profile — send an enquiry with your territory and current prescriber base.

Manufactured at WHO-GMP compliant units at Sai Road, Baddi, Himachal Pradesh, under Edmund Healthcare Pvt. Ltd. Halefem Gynae is a marketing and distribution company and does not own its manufacturing — a distinction worth checking with any supplier, because “WHO-GMP certified” is not a claim a marketing company can hold.

Trade information for pharmaceutical distributors and franchise partners. Prescription-only medicine, supplied to holders of a valid drug licence. This page is not medical advice, contains no dosage guidance, and is not product promotion to the public.